Zero to hero: the peculiar case of Orphacol | PharmaBoardroom
written on 06.03.2014
Tags:
,

Zero to hero: the peculiar case of Orphacol

TAGS: ,

Orphacol has come full circle. It has just been announced that the orphan drug – for the treatment of inborn errors in primary bile synthesis, a rare and potentially fatal condition affecting about 100 people in Europe – has just earned the…

Latest Report